Risk factors for liver disease in chronic hemolytic anemia
Part of Blood & lymphatic, Digestive system, Immune system & allergy, Lungs & breathing clinical trials.
This study looks at why people with chronic hemolytic anemia, such as thalassemia and sickle cell disease, may develop liver problems. The goal is to find common risk factors so doctors can better monitor and protect liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have thalassemia or sickle cell disease
- You have never had liver disease from alcohol use
- You have never had cancer
- You have never had autoimmune hepatitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with advanced chronic liver disease to find ways to predict when they might get worse or develop liver cancer. Researchers hope to use this information to prevent complications and improve care.
This observational study looks at people with thalassemia, sickle cell disease, or other inherited anemia who have COVID-19. It aims to learn how COVID affects these conditions and may help improve care planning.
This study looks at how common liver problems are in children with congenital heart disease. It is an observational study, meaning no treatments are given; the goal is simply to understand liver health in this group better.
This study looks at how blood clotting, inflammation, and blood vessels change in people with chronic liver disease or cirrhosis. Your blood tests may help researchers understand what drives the disease and could guide future care.
This study looks at how cancers occur and what they look like in people with certain inherited blood disorders, such as beta-thalassemia, hemoglobin H disease, and sickle cell disease. It may help doctors better understand cancer patterns in these conditions so care can be improved.
This research study helps doctors identify the genetic reason why some people have hemolytic anemia (a condition where red blood cells break down too quickly). Researchers will study patients with this condition and their family members to understand the underlying cause and potentially improve diagnosis and treatment.
Hear when a new Liver Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.